Gout: Update on Some Pathogenic and Clinical Aspects
- 1 May 2006
- journal article
- review article
- Published by Elsevier in Rheumatic Disease Clinics of North America
- Vol. 32 (2) , 295-311
- https://doi.org/10.1016/j.rdc.2006.03.001
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Evil humors take their toll as innate immunity makes gouty joints TREM‐bleArthritis & Rheumatism, 2006
- Induction of triggering receptor expressed on myeloid cells 1 in murine resident peritoneal macrophages by monosodium urate monohydrate crystalsArthritis & Rheumatism, 2006
- Pathogenesis of GoutAnnals of Internal Medicine, 2005
- Innate immunity conferred by toll‐like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal–induced inflammationArthritis & Rheumatism, 2005
- Mechanisms of inflammation in goutRheumatology, 2005
- TLR2 Signaling in Chondrocytes Drives Calcium Pyrophosphate Dihydrate and Monosodium Urate Crystal-Induced Nitric Oxide GenerationThe Journal of Immunology, 2005
- Proline‐rich tyrosine kinase 2 and Src kinase signaling transduce monosodium urate crystal–induced nitric oxide production and matrix metalloproteinase 3 expression in chondrocytesArthritis & Rheumatism, 2004
- Hyperuricemia and goutCurrent Rheumatology Reports, 2003
- Monosodium urate monohydrate crystal–induced inflammation in vivo: Quantitative histomorphometric analysis of cellular eventsArthritis & Rheumatism, 2002
- Inflammatory microcrystals stimulate interleukin‐6 production and secretion by human monocytes and synoviocytesArthritis & Rheumatism, 1989